8-K
filed May 19, 2023, 7:59 PM ET
ticker ACHC
CIK 0001520697
other
confidence high
sentiment neutral
materiality 0.20
Acadia Healthcare shareholders re-elect directors, approve incentive plan at annual meeting
Acadia Healthcare Company, Inc.
- Michael J. Fucci re-elected with 74.4M for, 12.3M against; Wade D. Miquelon with 65.7M for, 21.0M against.
- Amended incentive compensation plan approved (85.2M for, 1.5M against); term extended to March 2033.
- Non-binding advisory vote on named executive officer compensation passed (85.6M for, 1.1M against).
- Ernst & Young LLP ratified as auditor for fiscal 2023 (87.9M for, 0.6M against).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Acadia Healthcare Company, Inc. shareholders approved Non-binding advisory vote on named executive officer compensation at the 2023-05-18 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-05-18
Exact text from the filing
The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s Named Executive Officers (as defined in the Company’s definitive proxy statement filed with the SEC on April 7, 2023), by the following vote: For Against Abstain Broker Non-Votes 85,589,978 1,132,077 21,821 1,735,435
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Acadia Healthcare Company, Inc. shareholders approved Ratification of independent registered public accounting firm at the 2023-05-18 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-05-18
Exact text from the filing
The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, by the following vote: For Against Abstain 87,880,701 576,757 21,853
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Acadia Healthcare Company, Inc. shareholders approved Amendment and restatement of the Incentive Compensation Plan at the 2023-05-18 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-05-18
Exact text from the filing
The Company’s stockholders approved an amendment and restatement of the Acadia Healthcare Company, Inc. Incentive Compensation Plan, by the following vote: For Against Abstain Broker Non-Votes 85,187,311 1,532,139 24,426 1,735,435
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Acadia Healthcare Company, Inc. shareholders approved Election of Class III Directors at the 2023-05-18 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-05-18
Exact text from the filing
The individuals listed below were elected to serve as Class III directors until the Company’s annual meeting of stockholders in 2026 or until their successors have been elected and take office. The voting results were as follows: For Against Abstain Broker Non-Votes Michael J. Fucci 74,423,272 12,296,852 23,752 1,735,435 Wade D. Miquelon 65,692,075 21,027,841 23,960 1,735,435
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.